Skip to main content
. 2020 Aug 13;15(8):e0236510. doi: 10.1371/journal.pone.0236510

Table 1. Maternal characteristics of HIV positive mothers (n = 36) stratified by HIV status of their infants.

HIV+ Mothers p-value
HIV- Infants HIV+ Infants
Maternal Characteristic n = 27 n = 9
Age, y 32.6±5.0 30.9±5.0 0.38
Height, cm 159.6±6.3 158.9±7.7 0.78
Body weight, kg 60.6±9.8 57.2±9.3 0.36
BMI, kg/m2 23.8±3.8 22.6±4.0 0.43
< 18.5, % 4 11 0.71
18.5–24.9, % 63 67
25.0–29.9, % 26 22
≥ 30.0, % 7 0
Season of examination
Spring/Summer, % 11 78 <0.001
Fall/Winter, % 89 22
cART, % 70 67 0.84
Efavirenz-containing regimens, % 37 56 0.33
Serum vitamin D and nutrition indicators*
25(OH)D, ng/mL 40.5±2.5 27.2±4.9 0.03
< 20.0, % 11 11 0.002
20–29.9, % 4 56
≥ 30.0, % 85 33
1,25(OH)D, pg/mL 41.8±4.9 44.8±9.4 0.79
PTH, pg/mL 35.7±2.7 24.6±5.2 0.09
Magnesium, mmol/L 0.96±0.02 0.87±0.04 0.06
Phosphorus, mmol/L 1.10±0.03 1.14±0.05 0.53
Calcium, mmol/L 2.26±0.02 2.25±0.04 0.49
Albumin, g/L 39.1±0.7 35.6±1.3 0.04

Data are presented as mean ± standard deviation (SD) or a least square means (LSM) ± standard error of the mean (SEM) for continuous variables, and as percent for distribution of categorical variables. HIV = human immunodeficiency virus; BMI = body mass index; cART = combined antiretroviral therapy; 25(OH)D = 25-hydroxyvitamin D; 1,25(OH)D = 1,25-dihydroxyvitamin D; PTH = intact parathyroid hormone.

*Results are reported as LSM ± SEM from analyses of covariance, adjusting for season of examination.

†Sample sizes are n = 26 for mothers of HIV- infants and n = 9 for mothers of HIV+ infants.